Open AccessLow rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients
Author(s) -
Markus Bickel,
Imke Wieters,
Pavel Khaykin,
Gabi Nisius,
Annette Haberl,
Christoph Stephan,
Nils von Hentig,
Eva Herrmann,
Hans Wilhelm Doerr,
H.-R. Brodt,
Regina Allwinn
Publication year - 2010
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e3283398da1
Subject(s) - seroconversion , medicine , vaccination , hemagglutination assay , titer , immunology , virology , antibody , antibody titer
To determine rates of seroconversion after single vaccination with a novel split virion, inactivated, adjuvanted pandemic H1N1 influenza vaccine (A/California/7/2009) in HIV-1-infected patients (ClinicalTrials.gov Identifier: NCT01017172).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom